Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hinsdale Hematology Oncology Associates is a specialized medical practice providing comprehensive care for patients with cancer and blood disorders in the Illinois region. The practice offers a wide array of clinical services, including chemotherapy, immunotherapy, and advanced hematologic diagnostics across multiple suburban Chicago locations. While primarily a clinical service provider, the group has historically participated in clinical research trials, offering patients access to emerging therapeutic modalities. In 2022, the practice was acquired by Illinois CancerCare, a move designed to enhance the depth of sub-specialization and clinical resources available to its patient base. The transition integrated the practice into a larger regional network while maintaining its focus on personalized, community-based oncology care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hinsdale Hematology Oncology Associates.